Literature DB >> 15757760

Controlling the kinetics of transgene expression by plasmid design.

Nelson S Yew1.   

Abstract

While a vast array of liposomes, peptides, and molecular conjugates have been evaluated for nonviral gene transfer, the entity containing the actual gene itself is almost always a plasmid. The layout of most plasmid DNA (pDNA) vectors is usually quite simple, consisting of a promoter, transgene, polyadenylation signal, and a backbone that permits propagation of the plasmid in bacteria. Additional sequence elements and modifications can be incorporated to influence the stability of gene expression and retention of the pDNA molecule in a given tissue. This review describes the different choices that can be made when designing a pDNA vector for transient, sustained, or regulated expression. The choice of promoter is a major determinant governing the kinetics of expression, but other factors, such as CpG content and the topological form of the pDNA are also influential. Vectors can also be designed to respond to the local environment of a given cell or tissue, or engineered to respond to a small molecule drug.

Mesh:

Year:  2005        PMID: 15757760     DOI: 10.1016/j.addr.2004.12.009

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  7 in total

Review 1.  Gene therapy: a pharmacokinetic/pharmacodynamic modelling overview.

Authors:  Zinnia P Parra-Guillén; Gloria González-Aseguinolaza; Pedro Berraondo; Iñaki F Trocóniz
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

Review 2.  Strategies to improve drug delivery across the blood-brain barrier.

Authors:  Albertus G de Boer; Pieter J Gaillard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

3.  Layered PLG scaffolds for in vivo plasmid delivery.

Authors:  Christopher B Rives; Anne des Rieux; Marina Zelivyanskaya; Stuart R Stock; William L Lowe; Lonnie D Shea
Journal:  Biomaterials       Date:  2008-10-17       Impact factor: 12.479

4.  Enhancement of reporter gene detection sensitivity by insertion of specific mini-peptide-coding sequences.

Authors:  J Cutrera; D Dibra; X Xia; S Li
Journal:  Cancer Gene Ther       Date:  2009-08-28       Impact factor: 5.987

5.  The contribution of plasmid design and release to in vivo gene expression following delivery from cationic polymer modified scaffolds.

Authors:  Misael O Avilés; Chia-Hsuan Lin; Marina Zelivyanskaya; John G Graham; Ryan M Boehler; Phillip B Messersmith; Lonnie D Shea
Journal:  Biomaterials       Date:  2009-11-04       Impact factor: 12.479

6.  Plasmid CpG depletion improves degree and duration of tumor gene expression after intravenous administration of polyplexes.

Authors:  Holger K de Wolf; Nina Johansson; Anh-Thy Thong; Cor J Snel; Enrico Mastrobattista; Wim E Hennink; Gert Storm
Journal:  Pharm Res       Date:  2008-03-04       Impact factor: 4.200

7.  Homogeneity and persistence of transgene expression by omitting antibiotic selection in cell line isolation.

Authors:  Weimin L Kaufman; Ibrahim Kocman; Vishal Agrawal; Hans-Peter Rahn; Daniel Besser; Manfred Gossen
Journal:  Nucleic Acids Res       Date:  2008-08-05       Impact factor: 16.971

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.